Perinatal Consensus Conference
When should maternal testing for red cell antigens by cffDNA be considered?
When should maternal testing for red cell antigens by cffDNA be considered? presentation by Dr. Barbra de Vrijer
May 25, 2022
Postnatal Cord Blood Testing
Postnatal Cord Blood Testing by Omar Hajjaj
May 25, 2022
First Trimester Anti-D Prophylaxis
First Trimester Anti-D Prophylaxis presentation by Dr. Susan Ellis
May 25, 2022
When should RhD genotyping be performed for pregnant D negative women?
When should RhD genotyping be performed for pregnant D negative women? presentation by Dr. Nancy Robitaille
May 25, 2022
Second and third trimester FMH testing and anti-D prophylaxis: Review of routine administration and special situations
Second and third trimester FMH testing and anti-D prophylaxis Review of routine administration and special situations presentation by Dr. Nadine Shehata
May 25, 2022
Prenatal Monitoring Strategies for Lower-risk RBC Alloantibodies
Prenatal Monitoring Strategies for Lower-risk RBC Alloantibodies presentation by Dr. Matthew Yan
May 25, 2022
The group and screen at 28 weeks
The group and screen at 28 weeks presentation by Dr. Jon Barrett
May 25, 2022
The triage group and screen
The triage group and screen presentation by Jeannie Callum
Dir. of Transfusion Medicine Kingston Health Sciences Centre Queen’s University
May 25, 2022
Fetal maternal hemorrhage testing: the why, how & when
Fetal maternal hemorrhage testing: the why, how & when presentation by Heather VanderMeulen, MD, MSc, FRCPC
Transfusion Medicine Fellow Canadian Blood Services
May 25, 2022
K Titres
K Titres presentation by Dr. Elina Koumoutsea
May 25, 2022